Dr. Said is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-8094Fax+1 608-265-8852
Summary
- Adnan Said, MD is a Gastroenterologist based in Madison, WI, with subspecialties in Hepatology & Liver Transplantation. He completed his education and training at the University of Wisconsin Hospitals and Clinics and Aga Khan Medical College. His expertise lies in hepatology, viral hepatitides, non-alcoholic fatty liver disease, alcoholic liver disease, and acute fatty liver. Dr. Said has contributed to numerous notable publications and participated in various clinical trials, largely centered on liver health and colorectal cancer. He has been recognized as one of the Best Doctors in America and has received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation in 2011. He has served on the American Association for Study of Liver Diseases (AASLD) Practice Guidelines committee, AASLD Public Policy Committee and currently as chair of the AASLD Clinical Research Committee
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Gastroenterology, 2000 - 2003
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1997 - 2000
- Aga Khan Medical CollegeClass of 1995
Certifications & Licensure
- WI State Medical License 1999 - 2025
- CA State Medical License 2008 - 2023
- MI State Medical License 2004 - 2017
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Best Doctors in America
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression Start of enrollment: 2004 Aug 01
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Start of enrollment: 2012 Apr 30
- Technical Validation of MR Biomarkers of Obesity-Associated NAFLD Start of enrollment: 2018 May 04
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPortal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.Kelly Hu, Mai Sedki, Allison Kwong, Andrew Kesselman, Kanti Pallav Kolli
Alimentary Pharmacology & Therapeutics. 2024-11-05 - Predictors of long-term clinical outcomes after TIPS: An ALTA group study.Yael R Nobel, Justin R Boike, Nikhilesh R Mazumder, Bartley Thornburg, Rachel Hoffman
Hepatology. 2024-09-10 - 2 citationsDietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database.Mary Nemer, Fauzia Osman, Adnan Said
Annals of Hepatology. 2024-02-25
Authored Content
- Immunotherapy for HCC: limitations in patients with NASHMarch 2023
Press Mentions
- Liver Diseases Claiming More Lives in SD, Experts SayJune 24th, 2019
- S.D. Has High Rate of Death Due to Liver DiseasesJune 22nd, 2019
Professional Memberships
- American Association for the Study of liver diseasesFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: